March 19-21, 2024 | Pre-Conference Workshops on March 18, 2024
Philadelphia Marriott Downtown in Philadelphia, PA
Exclusive Offer – Be sure to use your exclusive promo code 24DC10 to save 10% off* of your registration.
It is our responsibility as an industry to ensure patients have access to the life-changing therapies they need.
How does PAP – Patient Assistance & Access Programs help us reach this goal?
Download the agenda and register today – Be sure to use your exclusive promo code 24DC10 to save 10% off* of your registration
With the demand for patient assistance growing each year, industry collaboration is vital in meeting patients’ needs and navigating the access and reimbursement barriers we face daily.
What policy disruptions await in the new year that will inevitably slow access and affordability? Is your program up to par with industry standards? How are we improving health equity to bridge the gaps in healthcare?
PAP – Patient Assistance & Access Programs, taking place March 19-21 in Philadelphia, PA, provides an essential forum for industry to collaborate and uncover the answers to these questions and more to define best practice for PAP programs. Experts come together and provide clarity on current changes in legislation and policy, methods for program optimization, the risks associated with AFPs, improving patient education for better patient outcomes and so much more. Never a shortage of timely discussions, join stakeholders from across the industry as they dive into methods and strategies to take on the challenges ahead.
What can you expect?
Tackle the hottest topics facing industry right now, including:
- State of the Industry—The Changing Landscape of Healthcare Coverage and Access
- Illuminating Health Equity—Bridging the Gaps in Healthcare, Education, and Partnerships
- Enforcement Panel—Focal Points and Priorities for 2024 and Beyond
- 3 Focused Tracks for a Customized Experience:
- Legal and Policy
- Patient Education
- Technology, Innovation and Operations
- Legal Address—Examining the Implications and Risks of Patient Assistance
- PAP 101- Back to the Basics
- Ensuring Compliance with Free Drug and Medication Assistance Programs
- Impacts of the Inflation Reduction Act – Dive into How Organizations are Planning for 2025 Changes
- Ask Me Anything Session with Leading Charitable Foundations
- PLUS! Join your peers one day early on March 18th for 3 hot topic, intensive workshops:
- Advocacy and Engagement
- Alternative Funding Programs
- Product Launch and Commercialization
- Corey Ford, MHA, Vice President of Reimbursement and Policy Insights, Cencora
- Kevin L. Hagan, President and CEO, PAN Foundation
- Doreen Rice, Director, Patient Assistance Programs, AstraZeneca
- Page Buchanan, Vice President, Amgen Safety Net Foundation; Senior Manager, Patient Assistance Programs and OUS Product Donations, Amgen
- Harmeet Dhillon, Head of Public Policy, GlaxoSmithKline
- Joshua Walsh, Director of Patient Access, AbbVie
- Rachel Thorpe, Executive Director, Otsuka Patient Assistance Foundation, Inc.
- Liz Austin, Patient Foundation Head, Genentech
- Amy Yarcich, Executive Director, Rx Partnership
- Alisa Vidulich Casavant, Policy Director, Arthritis Foundation
- And more!
PAP is back as part of Access USA, the access event bringing together three industry-leading conferences under one roof. Benefit from robust networking opportunities with all Access USA participants (that is an expected 600+ access professionals!), expand your network and establish powerful partnerships.
Exclusive Offer – Download the agenda and register today – Be sure to use your exclusive promo 24DC10 to save 10% off* of your registration.
Informa Connect will see you there!
*Cannot be combined with other offers, promotions or applied to an existing registration. Other restrictions may apply.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net).
No comments:
Post a Comment